Akèy › Twoub Anksyete Jeneralize
Etid klinik pou Twoub Anksyete Jeneralize ap rekrite nan Etazini
30 etid pou Twoub Anksyete Jeneralize ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Philadelphia, PA6 etid
- Los Angeles, CA5 etid
- Austin, TX4 etid
- Brooklyn, NY4 etid
- Miami, FL4 etid
- Boston, MA4 etid
- Dallas, TX4 etid
- Bellevue, WA3 etid
- San Bernardino, CA3 etid
- Oklahoma City, OK3 etid
- Tampa, FL3 etid
- Atlanta, GA3 etid
- Oceanside, CA3 etid
- New York City, NY3 etid
- Columbus, OH3 etid
- Chicago, IL3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Florid7 etid
- Georgia4 etid
- Illinois3 etid
- Kalifòni9 etid
- Massachusetts5 etid
- Michigan4 etid
- New Jersey3 etid
- New York9 etid
- Ohio5 etid
- Oklahoma3 etid
- Pennsylvania7 etid
- Texas11 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07807865Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 25, 2026 · NCT06480383Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06701903RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Sep 24, 2026 · NCT07489651A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07759128Device for Treating Generalized Anxiety
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07819773A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07767903Anxiety Skills Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07774481Testing Delivery Modalities of Team-Based CBT for Pediatric Anxiety in Community Health Settings.
Ap rekriteMande peman pou patisipan yo
Laj 5 a 18 · Tout sèks · Mizajou Jul 31, 2026 · NCT06934525Mindful Self-Compassion for Anxiety Disorders and Depression
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT05671419Oral Surgery Virtual Reality Glasses Study
Ap rekrite
Laj 16 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT06723158Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jul 16, 2026 · NCT06376734Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jun 17, 2026 · NCT06846320CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Jun 10, 2026 · NCT05467683Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT07430800Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
Ap rekrite
Laj 18 a 24 · Tout sèks · Mizajou Jun 5, 2026 · NCT06563310Triage Survey for Psychiatry Research Eligibility
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT05800925ACT for Individuals With MNCD and Their Care Partners
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT07239609Targeting Social Function in Anxiety and Eating Disorders
Ap rekrite
Laj 18 a 30 · Tout sèks · Mizajou May 5, 2026 · NCT06198023Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou May 5, 2026 · NCT07028216Enhancing Health in Rural Populations: Music as Therapy
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Apr 20, 2026 · NCT07538427Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
Ap rekriteFaz 3
Laj 18 a 45 · Tout sèks · Mizajou Mar 9, 2026 · NCT07123467Stepped Care Treatment for Anxiety Resilience
Ap rekrite
Laj 7 a 17 · Tout sèks · Mizajou Mar 2, 2026 · NCT07228143Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Feb 10, 2026 · NCT04557891Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou Feb 5, 2026 · NCT07389473Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.